Takeda Pharmaceutical Co., Ltd. (TKPHF) - OTCPK - Current
  • Nov. 30, 2015, 6:51 AM
    • Teva Pharmaceutical Industries (NYSE:TEVA) and Takeda Pharmaceutical (OTCPK:TKPHF)(OTCPK:TKPYY) form a joint venture in Japan with the aim of building a leadership position in the fast-growing generic medicines there. The government, trying to address the medical needs of its aging population, intends to reach 80% generic penetration in its drugs market by the end of fiscal year 2020.
    • The new business, expected to start operating in Q2 2016, will leverage Teva's extensive generics portfolio with Takeda's brand presence and distribution capabilities. Teva will be the majority owner with a 51% stake while Takeda will own 49%.
    | Nov. 30, 2015, 6:51 AM
  • Mar. 19, 2013, 8:18 AM

    NPS Pharmaceuticals (NPSP) has bought back the none-North American rights to two drugs from Takeda for $50M in shares and possible milestone payments, giving NPS with full global rights to the treatments. The drugs are Revestive (Gattex in the U.S.), a medicine for short bowel syndrome, and Preotact, a thyroid hormone replacement therapy. (PR)

    | Mar. 19, 2013, 8:18 AM
  • May 19, 2011, 5:54 AM

    Takeda Pharmaceutical (TKPHF.PK) agrees to buy closely-held Swiss rival Nycomed for €9.6B ($13.7B) in a move that will extend Takeda's reach into emerging markets. The price tag, which is slightly larger than had been expected, includes €3.6B of net debt.

    | May 19, 2011, 5:54 AM
  • May 18, 2011, 5:05 AM

    Takeda Pharmaceutical (TKPHF.PK), Asia's top drug maker, is reportedly set to announce the purchase of closely-held Swiss rival Nycomed as soon as this morning. The price tag is expected to be around ¥1T ($12B). (previously)

    | May 18, 2011, 5:05 AM
  • May 12, 2011, 4:30 AM
    Takeda Pharmaceutical (TKPHF.PK), Asia's top drug maker, is reportedly in talks to buy closely-held Swiss rival Nycomed. Sources say Takeda and Nycomed have discussed an offer above €8B ($11.4B) but that Nycomed may hold out for more than €10B.
    | May 12, 2011, 4:30 AM
Company Description
Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc.
Country: Japan